Evaluation of the effectiveness of metacarpophalengeal static splint on the adult patients with trigger finger

Evaluation of the effectiveness of metacarpophalengeal static splint on pain reduction and function improvement of the adult patients with trigger finger

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180804040685N3

Enrollment

Registered

2020-09-09

Start date

2020-04-20

Completion date

Unknown

Last updated

2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The adult patients with trigger finger. Trigger finger

Interventions

Intervention 1: Intervention group: Injection (40 mg Methyl prednisolone) in pulley A1 and splinting of MCP joint

All injections would be made via insulin needle (gauge 29, and length 2.1 inch). Intervention 2: Control group: Injection (40 mg Methyl prednisolone) in pulley A1

All injections would be made via insulin needle (gauge 29, and length 2.1 inch).

Eligibility

Sex/Gender

All

Age

20 Years to 80 Years

Inclusion criteria

Inclusion criteria: 20-80 y/o The individuals should not have received similar treatments before and during this study One affected finger No contraindication for injection All participants should receive and fill the consent form No contraindication for splinting SST>2

Exclusion criteria

Exclusion criteria: The patients with CNS disorder, peripheral neuropathy and osteoarthritis Who has proper cooperation in the course of study

Design outcomes

Primary

Measure	Time frame
Functional status. Timepoint: Beginning of the study (before intervention), one month and three months after intervention. Method of measurement: Boston assessment questionnaire.;Pain. Timepoint: Beginning of the study (before intervention), one month and three months after intervention. Method of measurement: Numeric pain rating.;The strength of the fingers. Timepoint: Beginning of the study (before intervention), one month and three months after intervention. Method of measurement: Dynamometer.;Stage of disease. Timepoint: Beginning of the study (before intervention), one month and three months after intervention. Method of measurement: Stages of stenosing tenosynovtits.	—

Measure

Time frame

Functional status. Timepoint: Beginning of the study (before intervention), one month and three months after intervention. Method of measurement: Boston assessment questionnaire.;Pain. Timepoint: Beginning of the study (before intervention), one month and three months after intervention. Method of measurement: Numeric pain rating.;The strength of the fingers. Timepoint: Beginning of the study (before intervention), one month and three months after intervention. Method of measurement: Dynamometer.;Stage of disease. Timepoint: Beginning of the study (before intervention), one month and three months after intervention. Method of measurement: Stages of stenosing tenosynovtits.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHamid Reza Fateh

Tehran University of Medical Sciences

hr-fateh@tums.ac.ir+98 21 8822 5880

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026